84 related articles for article (PubMed ID: 38512983)
1. WNT-β-catenin signalling - a versatile player in kidney injury and repair.
Schunk SJ; Floege J; Fliser D; Speer T
Nat Rev Nephrol; 2021 Mar; 17(3):172-184. PubMed ID: 32989282
[TBL] [Abstract][Full Text] [Related]
2. The role of HIF1α in renal cell carcinoma tumorigenesis.
Gudas LJ; Fu L; Minton DR; Mongan NP; Nanus DM
J Mol Med (Berl); 2014 Aug; 92(8):825-36. PubMed ID: 24916472
[TBL] [Abstract][Full Text] [Related]
3. Mice with renal-specific alterations of stem cell-associated signaling develop symptoms of chronic kidney disease but surprisingly no tumors.
Myszczyszyn A; Popp O; Kunz S; Sporbert A; Jung S; Penning LC; Fendler A; Mertins P; Birchmeier W
PLoS One; 2024; 19(3):e0282938. PubMed ID: 38512983
[TBL] [Abstract][Full Text] [Related]
4. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.
Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C
Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025
[TBL] [Abstract][Full Text] [Related]
5. NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma.
Wang Q; Ding H; He Y; Li X; Cheng Y; Xu Q; Yang Y; Liao G; Meng X; Huang C; Li J
Cancer Lett; 2019 Mar; 444():9-19. PubMed ID: 30543814
[TBL] [Abstract][Full Text] [Related]
6. Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis.
Wang SS; Gu YF; Wolff N; Stefanius K; Christie A; Dey A; Hammer RE; Xie XJ; Rakheja D; Pedrosa I; Carroll T; McKay RM; Kapur P; Brugarolas J
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16538-43. PubMed ID: 25359211
[TBL] [Abstract][Full Text] [Related]
7. SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling.
Chen L; Xie Y; Ma X; Zhang Y; Li X; Zhang F; Gao Y; Fan Y; Gu L; Wang L; Zhang X; Fu B
Mol Carcinog; 2020 Oct; 59(10):1159-1173. PubMed ID: 32794610
[TBL] [Abstract][Full Text] [Related]
8. Multilevel Regulation of β-Catenin Activity by SETD2 Suppresses the Transition from Polycystic Kidney Disease to Clear Cell Renal Cell Carcinoma.
Rao H; Li X; Liu M; Liu J; Feng W; Tang H; Xu J; Gao WQ; Li L
Cancer Res; 2021 Jul; 81(13):3554-3567. PubMed ID: 33910928
[TBL] [Abstract][Full Text] [Related]
9. An integrated organoid omics map extends modeling potential of kidney disease.
Lassé M; El Saghir J; Berthier CC; Eddy S; Fischer M; Laufer SD; Kylies D; Hutzfeldt A; Bonin LL; Dumoulin B; Menon R; Vega-Warner V; Eichinger F; Alakwaa F; Fermin D; Billing AM; Minakawa A; McCown PJ; Rose MP; Godfrey B; Meister E; Wiech T; Noriega M; Chrysopoulou M; Brandts P; Ju W; Reinhard L; Hoxha E; Grahammer F; Lindenmeyer MT; Huber TB; Schlüter H; Thiel S; Mariani LH; Puelles VG; Braun F; Kretzler M; Demir F; Harder JL; Rinschen MM
Nat Commun; 2023 Aug; 14(1):4903. PubMed ID: 37580326
[TBL] [Abstract][Full Text] [Related]
10. Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma.
Carter P; Schnell U; Chaney C; Tong B; Pan X; Ye J; Mernaugh G; Cotton JL; Margulis V; Mao J; Zent R; Evers BM; Kapur P; Carroll TJ
J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 34060480
[No Abstract] [Full Text] [Related]
11. Acute kidney injury promotes development of papillary renal cell adenoma and carcinoma from renal progenitor cells.
Peired AJ; Antonelli G; Angelotti ML; Allinovi M; Guzzi F; Sisti A; Semeraro R; Conte C; Mazzinghi B; Nardi S; Melica ME; De Chiara L; Lazzeri E; Lasagni L; Lottini T; Landini S; Giglio S; Mari A; Di Maida F; Antonelli A; Porpiglia F; Schiavina R; Ficarra V; Facchiano D; Gacci M; Serni S; Carini M; Netto GJ; Roperto RM; Magi A; Christiansen CF; Rotondi M; Liapis H; Anders HJ; Minervini A; Raspollini MR; Romagnani P
Sci Transl Med; 2020 Mar; 12(536):. PubMed ID: 32213630
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients.
Fendler A; Bauer D; Busch J; Jung K; Wulf-Goldenberg A; Kunz S; Song K; Myszczyszyn A; Elezkurtaj S; Erguen B; Jung S; Chen W; Birchmeier W
Nat Commun; 2020 Feb; 11(1):929. PubMed ID: 32066735
[TBL] [Abstract][Full Text] [Related]
13. Human Organoids: Tools for Understanding Biology and Treating Diseases.
Schutgens F; Clevers H
Annu Rev Pathol; 2020 Jan; 15():211-234. PubMed ID: 31550983
[TBL] [Abstract][Full Text] [Related]
14. A dream of single-cell proteomics.
Marx V
Nat Methods; 2019 Sep; 16(9):809-812. PubMed ID: 31406385
[No Abstract] [Full Text] [Related]
15. Tubuloids derived from human adult kidney and urine for personalized disease modeling.
Schutgens F; Rookmaaker MB; Margaritis T; Rios A; Ammerlaan C; Jansen J; Gijzen L; Vormann M; Vonk A; Viveen M; Yengej FY; Derakhshan S; de Winter-de Groot KM; Artegiani B; van Boxtel R; Cuppen E; Hendrickx APA; van den Heuvel-Eibrink MM; Heitzer E; Lanz H; Beekman J; Murk JL; Masereeuw R; Holstege F; Drost J; Verhaar MC; Clevers H
Nat Biotechnol; 2019 Mar; 37(3):303-313. PubMed ID: 30833775
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
